1. Most Discussed
  2. Gainers & Losers
PAA 3.4¢

Promising Cancer Treatment

  1. Market Cap $14m
    Cash $1.5m
    Revenues $1.5m-$2m per annum

    EpiChem the medical services division generates a small operating cash flow which helps fund Pitney the research arm of the company

    Pitneys lead drug PPL1 has been able to show reductions in key Cancerous Tumor Markers
    The drug is a new class of drug that is a first in kind and thus novel.

    The amazing part about the great news was the fact that PAA were doing a preliminary safety study on PPL1 (Phase 1) and yet the drug at its lowest dose was able to show a marked reduction of between 8% and 65% in 4 out of 4 patients taking part in the trial.

    Of further great importance is the fact that all participants in the trial are terminal cancer patients with not long to live suffering from aggressive forms of cancer and have failed other standards of care, so PAA and it's PPL1 is trying to treat the WORST of the WORST Cancer for which there's is no hope or cure.

    At less than $15m this little Aussie Battler could be on the path to finding that silver bullet in Oncology and Cancer Treatments

DISCLAIMER:
Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.

Top

Thank you for visiting HotCopper

We have detected that you are running ad blocking software.


HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.